UBS Group’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47 | Sell |
1,332
-3,121
| -70% | -$110 | ﹤0.01% | 8732 |
|
|
2025
Q1 | $343 | Buy |
+4,453
| New | +$343 | ﹤0.01% | 8498 |
|
|
2024
Q3 | – | Sell |
-5,090
| Closed | -$183 | – | 8384 |
|
|
2024
Q2 | $183 | Buy |
+5,090
| New | +$183 | ﹤0.01% | 7925 |
|
|
2023
Q3 | – | Sell |
-200
| Closed | -$8 | – | 8389 |
|
|
2023
Q2 | $8 | Buy |
+200
| New | +$8 | ﹤0.01% | 7663 |
|
|
2022
Q4 | – | Sell |
-1,392
| Closed | – | – | 9575 |
|
|
2022
Q3 | $0 | Hold |
1,392
| – | – | ﹤0.01% | 9330 |
|
|
2022
Q2 | $0 | Buy |
1,392
+1,200
| +625% | – | ﹤0.01% | 9362 |
|
|
2022
Q1 | $0 | Sell |
192
-8
| -4% | – | ﹤0.01% | 9274 |
|
|
2021
Q4 | $0 | Buy |
+200
| New | – | ﹤0.01% | 9174 |
|